サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650414

網膜静脈閉塞症の世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2034年）

Retinal Vein Occlusion Market; Treatment Type: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 241 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
網膜静脈閉塞症の世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2034年）
出版日: 2024年12月16日
発行: Transparency Market Research
ページ情報: 英文 241 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

網膜静脈閉塞症市場：調査範囲

TMRの調査レポート「網膜静脈閉塞症の世界市場」は、2024年～2034年の予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年～2034年の世界の網膜静脈閉塞症市場の収益と予測を提供しています。また、2024年～2034年の世界の網膜静脈閉塞症市場の複合年間成長率（CAGR%）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、網膜静脈閉塞症市場を推察しました。

市場スナップショット
2023年の市場規模 28億米ドル
2034年の市場規模 55億米ドル
CAGR 6.7%

当レポートでは、世界の網膜静脈閉塞症市場の競合情勢について調査しています。世界の網膜静脈閉塞症市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の網膜静脈閉塞症市場における企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測（2020年～2034年）

第5章 主要洞察

  • 規制シナリオ
  • PESTEL分析
  • 地域/国別のヘルスケア支出（医療費総額、米ドル/人、2022年）
  • 市場参入戦略
  • バリューチェーン分析
  • 治療アルゴリズム
  • 主要な業界イベント

第6章 世界の市場分析と予測：疾患タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：疾患タイプ別（2020年～2034年）
    • 中心
    • 分枝
  • 疾病タイプ別の市場の魅力

第7章 世界の市場分析と予測：治療タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：治療タイプ別（2020年～2034年）
    • 薬物治療
      • 抗血管内皮増殖因子（抗VEGF）薬
      • コルチコステロイド薬
    • レーザー治療
      • 網膜光凝固術
      • 焦点レーザー
    • 硝子体切除術
  • 治療タイプ別の市場の魅力

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：エンドユーザー別（2020年～2034年）
    • 病院および外来手術センター
    • 眼科クリニック
    • 小売薬局
    • その他
  • エンドユーザー別の市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州

第12章 アジア太平洋の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業：競合マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Bayer AG
    • Alimera Sciences
    • Abbivie
    • Annexin Pharmaceuticals AB
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • IRIDEX Corporation
    • Lumenis
    • Nidek Co., Ltd.
    • Regeneron Pharmaceuticals, Inc.
図表

List of Tables

  • Table 01: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Disease Type, 2020-2034
  • Table 02: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 03: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 04: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By End-user, 2020-2034
  • Table 06: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 09: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 10: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 11: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 12: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 15: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 16: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 17: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 18: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 19: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 21: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 22: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 23: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 24: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 25: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 27: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 28: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 29: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 30: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 31: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 33: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 34: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 35: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 36: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Retinal Vein Occlusion Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Retinal Vein Occlusion Market Value Share, by Disease Type, 2023
  • Figure 03: Global Retinal Vein Occlusion Market Value Share, By Treatment Type, 2023
  • Figure 04: Global Retinal Vein Occlusion Market Value Share, by End-user, 2023
  • Figure 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Disease Type, 2023 and 2034
  • Figure 06: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2023
  • Figure 07: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2034
  • Figure 08: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Disease Type, 2024-2034
  • Figure 09: Global Retinal Vein Occlusion Market Value (US$ Bn), by Central Retinal Vein Occlusion, 2020-2034
  • Figure 10: Global Retinal Vein Occlusion Market Value Share Analysis, by Central Retinal Vein Occlusion, 2023 and 2034
  • Figure 11: Global Retinal Vein Occlusion Market Value (US$ Bn), by Branch Retinal Vein Occlusion, 2020-2034
  • Figure 12: Global Retinal Vein Occlusion Market Value Share Analysis, by Branch Retinal Vein Occlusion, 2023 and 2034
  • Figure 13: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 14: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2023
  • Figure 15: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2034
  • Figure 16: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 17: Global Retinal Vein Occlusion Market Value (US$ Bn), by Pharmacological Treatment, 2020-2034
  • Figure 18: Global Retinal Vein Occlusion Market Value Share Analysis, by Pharmacological Treatment, 2023 and 2034
  • Figure 19: Global Retinal Vein Occlusion Market Value (US$ Bn), by Laser Treatment, 2020-2034
  • Figure 20-: Global Retinal Vein Occlusion Market Value Share Analysis, by Laser Treatment, 2023 and 2034
  • Figure 21: Global Retinal Vein Occlusion Market Value (US$ Bn), by Vitrectomy, 2020-2034
  • Figure 22: Global Retinal Vein Occlusion Market Value Share Analysis, by Vitrectomy, 2023 and 2034
  • Figure 23: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By End-user, 2023 and 2034
  • Figure 24: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2023
  • Figure 25: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2034
  • Figure 26: Global Retinal Vein Occlusion Market Attractiveness Analysis, By End-user, 2024-2034
  • Figure 27: Global Retinal Vein Occlusion Market Value (US$ Bn), by Hospitals and Ambulatory Surgical Centers, 2020-2034
  • Figure 28: Global Retinal Vein Occlusion Market Value Share Analysis, by Hospitals and Ambulatory Surgical Centers, 2023 and 2034
  • Figure 29: Global Retinal Vein Occlusion Market Value (US$ Bn), by Ophthalmology Clinics, 2020-2034
  • Figure 30: Global Retinal Vein Occlusion Market Value Share Analysis, by Ophthalmology Clinics, 2023 and 2034
  • Figure 31: Global Retinal Vein Occlusion Market Value (US$ Bn), by Retail Pharmacies, 2020-2034
  • Figure 32: Global Retinal Vein Occlusion Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 33: Global Retinal Vein Occlusion Market Value (US$ Bn), By Others, 2020-2034
  • Figure 34: Global Retinal Vein Occlusion Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 35: Global Retinal Vein Occlusion Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2023
  • Figure 37: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2034
  • Figure 38: Global Retinal Vein Occlusion Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 39: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Retinal Vein Occlusion Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 43: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 44: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 45: North America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 46: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 47: North America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 48: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 49: Europe Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 50: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 51: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 52: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 53: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 54: Europe Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 55: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 56: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 57: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 58: Asia Pacific Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 59: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 61: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 62: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 63: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 64: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Latin America Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 70: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 71: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 72: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 73: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 74: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 75: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Middle East & Africa Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 79: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 80: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 81: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 82: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 83: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL60489

Retinal Vein Occlusion Market - Scope of Report

TMR's report on the global retinal vein occlusion market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global retinal vein occlusion market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global retinal vein occlusion market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the retinal vein occlusion market.

Market Snapshot
Market Value in 2023US$ 2.8 Bn
Market Value in 2034US$ 5.5 Bn
CAGR6.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global retinal vein occlusion market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global retinal vein occlusion market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global retinal vein occlusion market.

The report delves into the competitive landscape of the global retinal vein occlusion market. Key players operating in the global retinal vein occlusion market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global retinal vein occlusion market profiled in this report.

Key Questions Answered in Global retinal vein occlusion Market Report:

  • What is the sales/revenue generated by retinal vein occlusion across all regions during the forecast period?
  • What are the opportunities in the global retinal vein occlusion market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Retinal Vein Occlusion Market - Research Objectives and Research Approach

The comprehensive report on the global retinal vein occlusion market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global retinal vein occlusion market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global retinal vein occlusion market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Retinal Vein Occlusion Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Retinal Vein Occlusion Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. PESTLE Analysis
  • 5.3. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
  • 5.4. Go-to-Market Strategies for Retinal Vein Occlusion Market
  • 5.5. Value Chain Analysis
  • 5.6. Treatment Algorithm
  • 5.7. Key Industry Events

6. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Disease Type, 2020-2034
    • 6.3.1. Central Retinal Vein Occlusion
    • 6.3.2. Branch Retinal Vein Occlusion
  • 6.4. Market Attractiveness By Disease Type

7. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Treatment Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Treatment Type, 2020-2034
    • 7.3.1. Pharmacological Treatment
      • 7.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 7.3.1.2. Corticosteroid Drugs
    • 7.3.2. Laser Treatment
      • 7.3.2.1. Panretinal Photocoagulation
      • 7.3.2.2. Focal Laser
    • 7.3.3. Vitrectomy
  • 7.4. Market Attractiveness By Treatment Type

8. Global Retinal Vein Occlusion Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals and Ambulatory Surgical Centers
    • 8.3.2. Ophthalmology Clinics
    • 8.3.3. Retail Pharmacies
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Retinal Vein Occlusion Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Disease Type, 2020-2034
    • 10.2.1. Central Retinal Vein Occlusion
    • 10.2.2. Branch Retinal Vein Occlusion
  • 10.3. Market Value Forecast By Treatment Type, 2020-2034
    • 10.3.1. Pharmacological Treatment
      • 10.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 10.3.1.2. Corticosteroid Drugs
    • 10.3.2. Laser Treatment
      • 10.3.2.1. Panretinal Photocoagulation
      • 10.3.2.2. Focal Laser
    • 10.3.3. Vitrectomy
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals and Ambulatory Surgical Centers
    • 10.4.2. Ophthalmology Clinics
    • 10.4.3. Retail Pharmacies
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Disease Type
    • 10.6.2. By Treatment Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Retinal Vein Occlusion Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Disease Type, 2020-2034
    • 11.2.1. Central Retinal Vein Occlusion
    • 11.2.2. Branch Retinal Vein Occlusion
  • 11.3. Market Value Forecast By Treatment Type, 2020-2034
    • 11.3.1. Pharmacological Treatment
      • 11.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 11.3.1.2. Corticosteroid Drugs
    • 11.3.2. Laser Treatment
      • 11.3.2.1. Panretinal Photocoagulation
      • 11.3.2.2. Focal Laser
    • 11.3.3. Vitrectomy
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals and Ambulatory Surgical Centers
    • 11.4.2. Ophthalmology Clinics
    • 11.4.3. Retail Pharmacies
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Disease Type
    • 11.6.2. By Treatment Type
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Retinal Vein Occlusion Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Disease Type, 2020-2034
    • 12.2.1. Central Retinal Vein Occlusion
    • 12.2.2. Branch Retinal Vein Occlusion
  • 12.3. Market Value Forecast By Treatment Type, 2020-2034
    • 12.3.1. Pharmacological Treatment
      • 12.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 12.3.1.2. Corticosteroid Drugs
    • 12.3.2. Laser Treatment
      • 12.3.2.1. Panretinal Photocoagulation
      • 12.3.2.2. Focal Laser
    • 12.3.3. Vitrectomy
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals and Ambulatory Surgical Centers
    • 12.4.2. Ophthalmology Clinics
    • 12.4.3. Retail Pharmacies
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Disease Type
    • 12.6.2. By Treatment Type
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Retinal Vein Occlusion Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Disease Type, 2020-2034
    • 13.2.1. Central Retinal Vein Occlusion
    • 13.2.2. Branch Retinal Vein Occlusion
  • 13.3. Market Value Forecast By Treatment Type, 2020-2034
    • 13.3.1. Pharmacological Treatment
      • 13.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 13.3.1.2. Corticosteroid Drugs
    • 13.3.2. Laser Treatment
      • 13.3.2.1. Panretinal Photocoagulation
      • 13.3.2.2. Focal Laser
    • 13.3.3. Vitrectomy
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals and Ambulatory Surgical Centers
    • 13.4.2. Ophthalmology Clinics
    • 13.4.3. Retail Pharmacies
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Disease Type
    • 13.6.2. By Treatment Type
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Retinal Vein Occlusion Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Disease Type, 2020-2034
    • 14.2.1. Central Retinal Vein Occlusion
    • 14.2.2. Branch Retinal Vein Occlusion
  • 14.3. Market Value Forecast By Treatment Type, 2020-2034
    • 14.3.1. Pharmacological Treatment
      • 14.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 14.3.1.2. Corticosteroid Drugs
    • 14.3.2. Laser Treatment
      • 14.3.2.1. Panretinal Photocoagulation
      • 14.3.2.2. Focal Laser
    • 14.3.3. Vitrectomy
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals and Ambulatory Surgical Centers
    • 14.4.2. Ophthalmology Clinics
    • 14.4.3. Retail Pharmacies
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Disease Type
    • 14.6.2. By Treatment Type
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Alimera Sciences
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Abbivie
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Annexin Pharmaceuticals AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. F. Hoffmann-La Roche AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Novartis AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. IRIDEX Corporation
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Lumenis
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Nidek Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Regeneron Pharmaceuticals, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments